Recent studies have revealed oncogenic and tumour-suppressive roles of HIF proteins in ccRCC instigation and propose that modification in the equilibrium of HIF-1α and HIF-2α activities can have a role in ccRCC progression and aggressiveness [12]. The gene discussed is EPAS1; the disease is neoplasm.